1. Bodei L, Cremonesi M, Grana CM, Chinol M, Baio SM, Severi S, et al. Yttrium-labelled peptides for therapy of NET. Eur J Nucl Med Mol Imaging. 2012;39:93–102.
2. Baum RP, Kulkarni HR, Carreras C. Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms. Semin Nucl Med. 2012;42(3):190–207.
3. Vishne TH, Ron IG. Strontium-89 (Sr-89) analgesia for rare thymic carcinoid tumor with bony metastases. Am J Clin Oncol Cancer Clin Trials. 1998;21(6):602–4.
4. Takeshima T, Namura K, Sekiguchi Z, Takizawa A, Tsuchiya F, Iwasaki A, et al. [A case of multiple bony pain due to metastatic malignant pheochromocytoma successfully treated with strontium-89]. Hinyokika kiyo Acta urologica Japonica. [Case Reports]. 2014;60(3):109–13.
5. Oshiro C, Kamigaki S, Arai T, Nakamura Y, Fukunaga M, Ichida W, et al. A case of thyroid medullary carcinoma with multiple painful bone metastases successfully treated with strontium-89 chloride. Gan to kagaku ryoho Cancer chemother. 2012;39(6):951–3.